Binder profile
ZINC403848
Virtual-screening candidate from ZINC.
Bound to: PA1330 — short-chain dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC403848- UniProt (similar protein)
P14061- Tanimoto
- 1.000
- Target protein
- PA1330
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 268.4
- LogP ≤ 5 3.74
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 37.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=OC[C@@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=O
InChI=1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18-/m1/s1InChI=1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18-/m1/s1
WKRLQDKEXYKHJB-UWWQBHOKSA-NWKRLQDKEXYKHJB-UWWQBHOKSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- EQI
- Homolog
- P14061
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC403848 →
- ZINC ZINC20 ZINC403848 →
- UniProt UniProt P14061 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC403848”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1330.
PDB 16
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).